Meeting
2012 Genitourinary Cancers Symposium
Tumor burden as an independent prognostic factor in metastatic renal cell carcinoma (mRCC).
Authors
Bernard J. Escudier
Institut Gustave Roussy, Villejuif, France
Bernard J. Escudier , Roberto Iacovelli , Emilie Lanoy , Laurence Albiges , Karim Fizazi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session E: Renal Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 30, 2012 (suppl 5; abstr 397)
DOI
10.1200/jco.2012.30.5_suppl.397
Abstract #
397
Poster Bd #
D3
Abstract Disclosures
Similar Posters
Poster
2015 Genitourinary Cancers Symposium
Prognostic biomarker exploration for patients with metastatic renal cell carcinoma receiving VEGFR TKI.
First Author: Inkeun Park
Poster
2014 Genitourinary Cancers Symposium
Treatment pattern and prognosis in Japanese patients with metastatic renal cell carcinoma (mRCC) with favorable or intermediate MSKCC risk factors in the era of molecular targeted therapy.
First Author: Nobuo Shinohara
Poster
2014 Genitourinary Cancers Symposium
Heterogeneity of intermediate prognosis patients (pts) with metastatic renal cell cancer (mRCC) treated with sunitinib.
First Author: Avishay Sella
Poster
2011 Genitourinary Cancers Symposium
Brain metastasis in metastatic renal cell carcinoma: Predictive factors of occurrence and survival with or without antiangiogenic therapy.
First Author: Marie Vanhuyse